Head of Investor Relations
Amneal Pharmaceuticals, Inc. (AMRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Amneal Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get AMRX alertsTony DiMeo is recorded as Head of Investor Relations at Amneal Pharmaceuticals, Inc. (AMRX). Tony DiMeo has spoken on 13 earnings calls across 1 company, most recently for Amneal Pharmaceuticals, Inc. on November 3, 2026. Amneal Pharmaceuticals, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Amneal Pharmaceuticals, Inc. includes Chintu Patel (CEO and Board Member), Chirag Patel (CEO and Board Member), Paul Meister (Chairman and Board Member) and 7 others.
“The earnings press release and presentation are available on the IR page of AMUEL.com. Certain statements made on this call regarding matters that are not historical facts, including but not limited to management's outlook or predictions are forward-looking statements that are based solely on information that is now…”
“Good morning, and thank you for joining Amnil Pharmaceuticals Second Quarter 2026 Earnings Call. Today, we issued a press release reporting Q2 results.”
“This morning, we issued a press release announcing Amniel agrees to acquire Kashiv Bioscientist and reporting preliminary Q1 results.”
“Good morning, and thank you for joining Amnil Pharmaceuticals Second Quarter 2025 Earnings Call. Today, we issued a press release reporting Q2 results.”
“Good morning and thank you for joining Amnil Pharmaceuticals 4th Quarter 2024 Earnings Call. Today, we issued a press release reporting Q4 results.”
Drug Manufacturers - Specialty & Generic · Healthcare
Head of Investor Relations
